One of the insidious biological features of gliomas is potential to invade normal brain tissue extensively, yet molecular mechanisms that dictate this locally invasive behavior remain poorly understood. To investigate the molecular basis of invasion by malignant gliomas, proteomic analysis was performed using a pair of canine glioma subclones-J3T-1 and J3T-2-that show different invasion phenotypes in rat brains but have similar genetic backgrounds. Two-dimensional protein electrophoresis of whole-cell lysates of J3T-1 (angiogenesis-dependent invasion phenotype) and J3T-2 (angiogenesis-independent invasion phenotype) was performed. Twenty-two distinct spots were recognized when significant alteration was defined as more than 1.5-fold change in spot intensity between J3T-1 and J3T-2. Four proteins that demonstrated increased expression in J3T-1, and 14 proteins that demonstrated increased expression in J3T-2 were identified using liquid chromatography-mass spectrometry analysis. One of the proteins identified was annexin A2, which was expressed at higher levels in J3T-1 than in J3T-2. The higher expression of annexin A2 in J3T-1 was corroborated by quantitative reverse transcription-PCR of the cultured cells and immunohistochemical staining of the rat brain tumors. Moreover, immunohistochemical analysis of human glioblastoma specimens showed that annexin A2 was expressed at high levels in the tumor cells that formed clusters around dilated vessels. These results reveal differences in the proteomic profiles between these two cell lines that might correlate with their different invasion profiles. Thus, 4 annexin A2 may be related to angiogenesis-dependent invasion.
INTRODUCTION
In our previous study, detailed histopathological observations of human glioblastoma tissue revealed that there are at least two invasive and angiogenic phenotypes: one dependent on angiogenesis and the other independent of angiogenesis. Glioma cells migrate along dilated vessels in angiogenesis-dependent invasion, while infiltration of single glioma cells into the brain tissue is unrelated to the vasculature in angiogenesis-independent invasion.
1,2 Moreover, we established two glioma cell lines (J3T-1 and J3T-2) that showed different invasion phenotypes when implanted in rat brains. 1,2 J3T-1 cells form comparatively well-demarcated and highly angiogenic tumors, while J3T-2 cells form tumors with obscure margins via single-cell infiltration into the normal brain parenchyma. J3T-1 and J3T-2 cells show angiogenesis-dependent and independent invasive patterns, respectively, in rat brain tumor models; these patterns resemble those of human glioblastoma invasion.
In the present study, this pair of cell lines was examined using a proteomics approach, including the use of two-dimensional gel electrophoresis (2DGE) and liquid chromatography-tandem mass spectrometry analysis (LC-MS/MS), to compare the proteomic profiles of these two cell lines with different invasion phenotypes.
MATERIALS AND METHODS

Cell Culture
7
The J3T canine glioma cell was a generous gift from Michael E. Berens MD, PhD (Translation Genomics Research Institute, Phoenix, AZ, USA). 3 Two cell lines-J3T-1 and J3T-2-were developed from the parental J3T cell line, as previously described. 1, 4 In brief, J3T cells (5 × 10 6 cells) were subcutaneously implanted into the flanks of two athymic mice (NCr/Sed, nu/nu, 20 g). After 6 weeks, two tumors were established in each animal. These tumors were harvested in a sterile fashion, minced with a scalpel into 1-mm 3 cubes, treated for 1 h with 1 mg/ml Collagenase/Dispase (Roche, Basel, Switzerland), and subsequently cultured in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units penicillin, and 0.1 mg streptomycin per milliliter. Both cell lines were derived from single subcutaneous tumors.
For enhanced visualization of J3T-1 and J3T-2 cells, cell lines were established that stably expressed green fluorescent protein (GFP), as previously described. 1 In brief, J3T-1 and J3T-2 cells were transfected with the pAcGFP1-C1 plasmid (Clontech Laboratories Inc, Mountain View, CA, USA), which encodes for GFP using the TransIT-LT1 reagent (Takara Bio Inc, Otsu, Japan) to obtain J3T-1G and J3T-2G, respectively. Cells were cultured in DMEM supplemented with 10% FBS, 100 units penicillin, and 0.1 mg streptomycin per milliliter in a standard tissue incubator at 37°C with a 5% CO 2 atmosphere.
2DGE
The 
Image Analysis of 2DGE Gels
Images of the SYPRO Ruby-stained gels were obtained using a FLA-3000 image analyzer (Fujifilm, Tokyo, Japan). The images were analyzed using PDQuest Advanced, version 8.0
(Bio-Rad); analysis included background subtraction, spot detection, and volume normalization. The intensity of each spot was quantified by calculating the spot volume after normalization to the local regression model. The intensities of three sets of matched spots of each J3T-1 and J3T-2 gel were compared, and a threshold ratio of 1.5 was used to screen for differences. Visual inspection confirmed the differences indicated by PDQuest analysis.
Protein Identification
The selected protein spots were manually excised from the gels after visualizing the spots with silver staining. After destaining and drying the excised spots, in-gel trypsin digestion using the Protein In-Gel Tryptic Digestion kit (Agilent Technologies, Santa Clara, CA, USA) was performed overnight at 30°C. The obtained peptide digests were analyzed using a fully automated nanoflow liquid chromatography-ion trap-tandem mass spectrometer (nLC-IT-MS/MS; Agilent 1100 LC/MSD Trap XCT Ultra, Agilent Technologies).
Protein identification was performed using the Spectrum Mill MS Proteomics Workbench platform (version A.03.02; Agilent Technologies), according to the workflow parameters specified by the manufacturer. The identification parameters were set as follows: database, NCBInr; species, Canis familialis; enzyme, trypsin; monoisotopic masses used; precursor mass tolerance (peptide tolerance), ±2.5 Da; product mass tolerance (MS/MS tolerance), ±0.8; fixed modification, carbamidomethylation (cysteine); and variable modification, oxidation (methionine). Two missed cleavages with trypsin were allowed and the instrument's setting was specified as ''ESI ion trap''.
The probability scores calculated by the software were used as the criteria for correct identification.
Quantitative reverse-transcription PCR (QRT-PCR)
Total RNA was isolated from cultured J3T-1 and J3T-2 cells using RNeasy ® Mini Kit (QIAGEN, Valencia, CA, USA) and reverse-transcribed with oligo dT primers using SuperScript III 
RESULTS
2DGE patterns and differential analysis of J3T-1 and J3T-2
The 2DGE gel images of J3T-1 and J3T-2 cells showed similar protein expression patterns, probably reflecting the genetic similarity of J3T-1 and J3T-2 (Fig. 1) .
Using the PDQuest 2DGE gel analysis software, approximately 2800 well-stained and clearly delineated protein spots were detected. Twenty-two spots showing more than 1.5-fold change in spot intensity; five of these protein spots were upregulated in J3T-1 and 17 were upregulated in J3T-2. These differentially expressed protein spots are illustrated with circles and spot numbers in Fig. 1A and 1B.
Proteins identified by LC-MS/MS
Differentially expressed protein spots were excised from the 2DGE gels and analyzed for protein identification by LC-MS/MS and database searching. As a result, 18 proteins were identified in those spots; these proteins are shown in Table 1 . The Spectrum Mill software calculates the MS/MS Search score as described below. Each peak assigned to an allowed fragment ion type for a candidate peptide sequence is given ''bonus points''. In contrast, each unassigned peak is given ''penalty points''. Penalty value is based on peak height, -(peak height / height of tallest peak).
MS/MS score is summation of these bonus points and penalty points, indicating probability of the protein. Thus, the higher score indicates the better probability. The identified proteins that were upregulated in J3T-1 included one metabolic enzyme, one storage protein, one structural protein, and The results of this proteomics-based analysis of the proteins involved in invasion were corroborated by immunohistochemical analysis of the J3T-1G and J3T-2G xenograft models. One of the identified proteins was annexin A2, which has been reported to be involved in tumor invasion and metastasis. [6] [7] [8] Therefore, this protein was further studied using both animal models and human glioma samples. The annexin A2 antibody was readily available for immunohistochemical analysis of the frozen sections. Intense staining of the annexin A2 protein in the cytoplasm of the J3T-1 tumor cells was observed, whereas almost no staining was observed in the J3T-2 tumor cells (Fig. 4 C-H), as expected based on the results of the proteomic analysis.
Immunohistochemical analysis of annexin A2 in human glioma samples
To analyze expression pattern of annexin A2 in relation to vasculature, immunohistochemical staining with anti-annexin A2 antibody was performed in 5 human glioblastoma samples. Patient's age, sex, tumor locations, and degree of annexin A2 expression are summarized in Table 2 . The center of the tumor comprised an area of high-density tumor cells which were negative or weakly positive for annexin A2. Marked angiogenesis, which was characterized by thick endothelial proliferation, was seen in the center and at the tumor borders. At the borders, clusters of annexin A2-positive tumor cells were observed around dilated vessels in all cases (Fig.   5A) . Furthermore, diffuse single cell infiltration from the tumor core to the surrounding normal brain parenchyma, which was independent of vascular structure, was observed. Those cells were mostly negative (four cases) or weakly positive (one case; Patient 3) for annexin A2 (Fig. 5B) .
DISCUSSION
To investigate the molecular basis of the invasive properties of malignant gliomas, proteomic analysis of the invasion-related proteins was performed using two unique sibling glioma cell lines, J3T-1 and J3T-2, which exhibit different aspects of human glioma invasion in situ.
Advantages of the proteomic method for identifying invasion-related proteins
This study describes how four proteins were observed in J3T-1 cells and 14 proteins were observed in J3T-2 cells, out of 2800 protein spots that were reproducibly identified on 2DGE gels at pH 5-8.
The similarities in the protein expression patterns on the 2DGE gel images of J3T-1 and J3T-2 cells reflect their genetic proximity. At the same time, significant differences in protein expression between these two cell lines do exist, which could be directly related to their invasive characteristics. Taken together, the proteomic method could be used to sensitively capture the features of the cell lines used in this study.
The results of these proteomic analyses were corroborated by the results of the QRT-PCR and immunohistochemical analyses. Nearly all proteins that were shown to be upregulated by the 2DGE method were also upregulated at the mRNA level. This method is simple, reproducible, and reliable and may prove useful for gaining a broader understanding of invasion in general as well as some of the advantages and pitfalls of other in vitro modeling systems.
As a shortcoming, 2DGE analysis usually cannot detect hydrophobic membrane proteins, proteins larger than 100 kDa, low-abundance proteins, 9 or proteins with pI values outside the pH range. 10 These limitations of standard 2DGE probably account for the less chance of this study to identify these types of proteins in J3T-1 and J3T-2 cells.
Advantages of the two subclones for proteomic analysis
There are several advantages in using invasive animal models and proteomic analysis to study the molecular basis of glioma invasion.
First, the animal models used in this study are one of the few models available for studying invasive glioma in experimental settings. 1, 2 Traditional animal glioma models do not exhibit invasive growth into the surrounding normal brain areas and have been criticized for not recapitulating the 20 main pathological features of human glioma. 11 Recently, several experimental glioma models showing varying degrees of invasion have been developed to study glioma cell invasion both in vitro and in vivo. 12, 13 Second, the two subclones that were established from the same parental cell line showed very different invasive phenotypes when inoculated in rat brains; however, the subclones have inherently similar genetic backgrounds. 4 These differences in phenotypes are supposed to arise from differences in genotype. This allowed for direct comparison of the differentially expressed proteins that characterize the phenotypic differences in their invasive capabilities.
Third, the animal models used in this study are reproducible and suitable for in vivo experiments. Therefore, candidate proteins that might affect the invasive capability of the tumor can be directly verified in vivo using these animal models.
Annexin A2 as a candidate invasion-related protein
One of the proteins identified, annexin A2, was expressed at higher levels in J3T-1 cells than in J3T-2 cells. Annexin A2 has been previously reported to be expressed on the tumor cell surface and to be involved in tumor invasion and metastasis. [6] [7] [8] Therefore, this protein's role in both animal models and human glioma samples was further examined.
Annexins are a superfamily of closely related calcium-and membrane-binding proteins that are expressed in specific cell types. Annexins comprise numerous gene products, including 12 that are formed in vertebrates (group A annexins), and have been proposed to be involved in a variety of functions, including control of membrane structures, vesicle trafficking, cell division, apoptosis, calcium signaling, and growth regulation. [14] [15] [16] [17] [18] [19] [20] All annexins share a characteristic molecular structure that consists of a variable N-terminal domain and a highly conserved C-terminal domain, which is also called the annexin core. The core domain of annexin A2 harbors several Ca 2+ -binding sites and one actin-binding domain, whereas the N-terminal domain contains the binding site for the cellular ligand S100A10 and a Ca 2+ -independent membrane-binding domain. In cells, annexin A2 exists either as a monomer or as a heterotetrameric complex with S100A10. 21 Cell-surface annexin A2 has been shown to be a receptor/binding protein for both proteases (cathepsin B, plasminogen, and tissue-type plasminogen activator [tPA]) and extracellular matrix proteins (type I collagen and tenascin C) that are involved in tumor invasion and metastasis. [6] [7] [8] tPA has been shown to bind specifically to annexin A2 on the extracellular membrane of pancreatic cancer cells where it activates plasmin production and promotes tumor cell invasion. Annexin A2 is also expressed on the surface of vascular endothelial cells and has been shown to play a significant role in the regulation of tPA activities, plasminogen activation, and angiogenic functions. 22, 23 Increased expression of annexin A2 has been described in several types of tumor, including gastric carcinoma, 24 colorectal cancer, 25 pancreatic cancer, 26 breast cancer, 27 high-grade gliomas, 28 kidney cancer, 29 and vascular tumors. 30 In gliomas, annexin A2 has been identified more frequently in high-grade gliomas than in low grade gliomas 10 and is known to be an independent prognostic factor for poor clinical outcomes in patients with gliomas. 28, 31 Because of the ability of annexin A2 to interact with the actin cytoskeleton 14, 15, 32 and tumor-released proteases, 15 annexin A2 has become a promising candidate for influencing the invasion processes of glioma cells. Recent proteomic investigations of the pseudopodia extensions of highly migratory U87MG glioma cells have reported increased levels of annexin A2. 33 Tatenhorst et al. demonstrated that the migration of human glioma cells is significantly inhibited following annexin A2 depletion by RNA interference techniques in vitro. 34 Moreover, cell-surface annexin A2 is a receptor for angiostatin, which is an internal fragment of plasminogen. Annexin A2-dependent localized plasmin generation could contribute to angiogenesis and metastasis. Therefore, by blocking annexin A2-dependent plasmin production, e.g., by using angiostatin, it may be possible to develop new anti-angiogenic therapies. 35 A previous study reported that there are at least two invasive and angiogenic phenotypes-angiogenesis-dependent invasion and angiogenesis-independent invasion-and the novel animal glioma models used in this study were able to exhibit these phenotypes. 
Additional findings
Other noticeable proteins expressed higher in J3T-2 are heterogeneous nuclear ribonucleoproteins (hnRNPs) and Septin 11.
hnRNPs comprise a large family of proteins, including approximately 30 members that share some structural domains. The results obtained in our study show HNRNPK and HNRNPA1 are up-regulated in J3T-2. hnRNPs play important roles in telomere biogenesis, DNA repair, cellular signaling, and the regulation of expression at both the transcriptional and translational levels. 38 In addition, the nuclear shift of HNRNPK in dividing cells suggests a role in proliferating cells. 39 So far, there have been no detailed reports about functions of hnRNPs in gliomas.
Septins are a highly conserved subfamily of GTPases that play an important role in maintaining cytoskeletal structures necessary for the control of cell division, and are required for cytokinesis. 40 Kim et al. showed that septins are variably expressed in human brain tumor cell lines and specimens using antibodies against septins 2, 3, 4, 5, 6, 7, 9, and 11 in immunofluorescence and Western blot analysis. 41 In their study, septin 11 was immunolocalized along with the actin microfilamentous system, suggesting possible involvement in cell motility function.
These proteins are not fully investigated in terms of their function in glioma invasion and await further study.
CONCLUSION
Proteomic methods were used to compare the protein profiles of two cell lines with different invasive characteristics. This comparative analysis revealed the differential expression of several proteins that may be involved in tumor cell invasion. Among them, annexin A2 was shown to be one of the candidate proteins which are involved in angiogenesis-dependent invasion.
This study will help to elucidate the mechanisms involved in glioma cell invasion and will aid in the selection of targets for the molecular treatment of malignant gliomas. 
